Answers are grounded in this paper and cite their sources.
When personalised medicine offers patients individualised therapies, it has completely changed the healthcare industry. However, access to customised pharmaceuticals is frequently a difficulty for particular populations, including paediatrics, the elderly, and individuals with rare disorders. In order to overcome these obstacles, three-dimensional (3D) printing technology has become a viable option. In order to give a comprehensive picture of the current status of 3D printing technology in personalised medicine, this study will concentrate on its uses, advantages, and drawbacks in particular populations. Personalised pharmaceutical items, including tablets, capsules, and implants, are manufactured using a variety of 3D printing methods, materials, and software. The review emphasises how 3D printing technology can be used to better therapeutic outcomes for particular populations, decrease side effects, and improve drug adherence. In addition, we list the economic, technological, and regulatory barriers that must be overcome in order to promote the broad use of 3D printing in personalised medicine. A thorough framework for comprehending how 3D printing technology is transforming personalised treatment for particular populations is offered by this review.
No takes yet. Share an insight, caveat, or question.
Madhavi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: